Publication:
Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey

dc.contributor.authorFerhanoglu, B.
dc.contributor.authorBekoz, H.
dc.contributor.authorKaradurmus, N.
dc.contributor.authorPaydas, S.
dc.contributor.authorGulbas, Z.
dc.contributor.authorTurker, A.
dc.contributor.authorDemirkaya, M.
dc.contributor.authorIDArat, Mutlu/0000-0003-2039-8557
dc.contributor.authorIDYuksel, Meltem Kurt/0000-0003-0369-299X
dc.contributor.authorIDKaynar, Leylagul/0000-0002-2035-9462
dc.contributor.authorIDPaydas, Semra/0000-0003-4642-3693
dc.contributor.authorIDToprak, Selami K/0000-0001-7717-5827
dc.date.accessioned2020-06-21T13:19:13Z
dc.date.available2020-06-21T13:19:13Z
dc.date.issued2017
dc.departmentOMÜen_US
dc.department-temp[Ferhanoglu, B.] Koc Univ, Sch Med, Internal Med Hematol, Istanbul, Turkey -- [Ferhanoglu, B.] VKV Amer Hosp, Hematol, Istanbul, Turkey -- [Bekoz, H.] Medipol Univ, Fac Med, Internal Med Hematol, Istanbul, Turkey -- [Karadurmus, N.] Gulhane Res & Training Hosp, Internal Med Med Oncol, Ankara, Turkey -- [Paydas, S.] Cukurova Univ, Internal Med Hematol, Adana, Turkey -- [Gulbas, Z.] Anadolu Med Ctr, Hematol, Izmit, Turkey -- [Turker, A.en_US
dc.description22nd Congress of the European-Hematology-Association -- JUN 22-25, 2017 -- Madrid, SPAINen_US
dc.description.abstracten_US
dc.description.sponsorshipEuropean Hematol Assocen_US
dc.identifier.endpage85en_US
dc.identifier.issn0390-6078
dc.identifier.startpage84en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/12398
dc.identifier.volume102en_US
dc.identifier.wosWOS:000404127001176
dc.language.isoenen_US
dc.publisherFerrata Storti Foundationen_US
dc.relation.journalHaematologicaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleNivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkeyen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files